A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations

被引:13
作者
Dvorakova, D. [1 ,2 ]
Lengerova, M. [1 ,2 ]
Pospisilova, J. [1 ,2 ]
Palasek, I. [2 ]
Mayer, J. [2 ]
机构
[1] Univ Hosp Brno, Dept Internal Med, Ctr Mol Biol & Gene Therapy, Brno, Czech Republic
[2] Masaryk Univ, Brno, Czech Republic
关键词
D O I
10.1038/leu.2008.268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:793 / 796
页数:5
相关论文
共 9 条
[1]   Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].
Cheson, BD ;
Bennett, JM ;
Kopecky, KJ ;
Büchner, T ;
Willman, CL ;
Estey, EH ;
Schiffer, CA ;
Döhner, H ;
Tallman, MS ;
Lister, TA ;
LoCocco, F ;
Willemze, R ;
Biondi, A ;
Hiddemann, W ;
Larson, RA ;
Löwenberg, B ;
Sanz, MA ;
Head, DR ;
Ohno, R ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649
[2]  
Chiu RWK, 2001, CLIN CHEM, V47, P667
[3]   Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations [J].
Chou, W-C ;
Tang, J-L ;
Wu, S-J ;
Tsay, W. ;
Yao, M. ;
Huang, S-Y ;
Huang, K-C ;
Chen, C-Y ;
Huang, C-F ;
Tien, H-F .
LEUKEMIA, 2007, 21 (05) :998-1004
[4]   Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease [J].
Chou, WC ;
Tang, JL ;
Lin, LI ;
Yao, M ;
Tsay, W ;
Chen, CY ;
Wu, SJ ;
Huang, CF ;
Chiou, RJ ;
Tseng, MH ;
Lin, DT ;
Lin, KH ;
Chen, YC ;
Tien, HF .
CANCER RESEARCH, 2006, 66 (06) :3310-3316
[5]   Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].
Falini, B ;
Mecucci, C ;
Tiacci, E ;
Alcalay, M ;
Rosati, R ;
Pasqualucci, L ;
La Starza, R ;
Diverio, D ;
Colombo, E ;
Santucci, A ;
Bigerna, B ;
Pacini, R ;
Pucciarini, A ;
Liso, A ;
Vignetti, M ;
Fazi, P ;
Meani, N ;
Pettirossi, V ;
Saglio, G ;
Mandelli, F ;
Lo-Coco, F ;
Pelicci, P ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266
[6]   Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice [J].
Falini, Brunangelo ;
Martelli, Maria Paola ;
Mecucci, Cristina ;
Liso, Arcangelo ;
Bolli, Niccolo ;
Bigerna, Barbara ;
Pucciarini, Alessandra ;
Pileri, Stefano ;
Meloni, Giovanna ;
Martelli, Massimo F. ;
Haferlach, Torsten ;
Schnittger, Susanne .
HAEMATOLOGICA, 2008, 93 (05) :775-779
[7]   Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features [J].
Falini, Brunangelo ;
Nicoletti, Ildo ;
Martelli, Massimo F. ;
Mecucci, Cristina .
BLOOD, 2007, 109 (03) :874-885
[8]   Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations [J].
Gorello, P. ;
Cazzaniga, G. ;
Alberti, F. ;
Dell'Oro, M. G. ;
Gottardi, E. ;
Specchia, G. ;
Roti, G. ;
Rosati, R. ;
Martelli, M. F. ;
Diverio, D. ;
Lo Coco, F. ;
Biondi, A. ;
Saglio, G. ;
Mecucci, C. ;
Falini, B. .
LEUKEMIA, 2006, 20 (06) :1103-1108
[9]   Rapid screening and sensitive detection of NPM 1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia [J].
Scholl, S. ;
Muegge, L.-O. ;
Landt, O. ;
Loncarevic, I. F. ;
Kunert, C. ;
Clement, J. H. ;
Hoeffken, K. .
LEUKEMIA RESEARCH, 2007, 31 (09) :1205-1211